Industry-Leading Insights for Advancing Medical Lighting Solutions
CLEVELAND, Oct. 15, 2024 /PRNewswire/ — Lumitex, a global leader in innovative medical lighting solutions, is excited to announce the release of its 2024 State of Medical Lighting Report. This comprehensive report delivers in-depth analysis and key insights designed to inform and advance the medical device industry.
Key Highlights of the 2024 State of Medical Lighting Report:
“We are thrilled to share the 2024 State of Medical Lighting Report with the medical device community,” said Matt Valego, Chief Commercial Officer at Lumitex. “Our engineering team is constantly pushing the boundaries of innovation in medical device lighting. As technology evolves, we’ve been involved in some truly groundbreaking projects that enhance patient care and make a real difference in people’s lives!”
The 2024 State of Medical Lighting Report is now available for download on the Lumitex website. To access the full report, click here.
About Lumitex:
Lumitex is a pioneering provider of advanced medical lighting solutions, dedicated to enhancing healthcare environments with innovative, efficient, and reliable lighting technologies. With a commitment to excellence and a focus on improving patient outcomes, Lumitex continues to lead the industry in developing cutting-edge lighting solutions for medical applications.
Contact Information:
Lindsay Jankovic
Marketing Manager
Phone: 440.973.0309
Email: ljankovic@lumitex.com
Website: lumitex.com
For further inquiries or to schedule an interview, please contact Lindsay Jankovic
SOURCE Lumitex, Inc.
Additional Hiring and Product Expansions Planned Through 2025BOSTON and TEL AVIV, Israel, April 10, 2025…
Novel IVL technology designed to deliver calcium fragmentation for treatment of moderate to severely calcified coronary…
Allergan Aesthetics Top 25 York Plastic Surgical Group and Deep Blue Med Spa have been…
Myeloma Action Month Global Campaign Celebrates Resilience, Strengthens Connections, and Inspires Hope in 52 Countries…
Industry leader in the development and application of cellular therapies, including CAR NK products, for…
SINGAPORE, April 10, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (“CUPR” or “the Company”),…